Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC TTA-A2 | 953778-63-7 | 99.33% | 378.39 | 10 MG
SDP

Supplier:  Medchemexpress LLC HY11182810MG

Encompass_Preferred

TTA-A2 is a potent, selective, and orally active T-type voltage-gated calcium channel antagonist with reduced pregnane X receptor (PXR) activation. It is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels. TTA-A2 can be used for the research of a variety of human neurological diseases, including sleep disorders and epilepsy.

  • Potent and selective T-type voltage-gated calcium channel antagonist
  • Reduced pregnane X receptor activation
  • Equally potent against Cav3.1 and Cav3.2 channels
  • Useful for research into neurological diseases such as sleep disorders and epilepsy

Catalog No. 50-004-38391


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.